Variant report

Variant	nsv563104
Chromosome Location	chr13:110951487-110960255
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:212)
CpG islands
(count:794)
Chromatin interactive
region (count:3)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:212 , 50 per page) page: 1 2 3 4 5

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr13:110951362-110951563	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr13:110958759-110961545	H1-hESC	embryonic stem cell:	n/a	n/a
3	BRCA1	chr13:110959973-110960116	H1-hESC	embryonic stem cell:	n/a	n/a
4	CEBPB	chr13:110957604-110958183	IMR90	lung:	n/a	chr13:110957969-110957981 chr13:110957742-110957754 chr13:110957948-110957960
5	CEBPB	chr13:110953920-110954250	IMR90	lung:	n/a	n/a
6	CEBPB	chr13:110952461-110953090	IMR90	lung:	n/a	chr13:110952603-110952616 chr13:110952620-110952633 chr13:110952890-110952901 chr13:110952738-110952751 chr13:110952890-110952903 chr13:110952890-110952903
7	CHD1	chr13:110951969-110962894	IMR90	lung:	n/a	chr13:110960921-110960931 chr13:110960926-110960936 chr13:110959544-110959554
8	CHD1	chr13:110959411-110960496	H1-hESC	embryonic stem cell:	n/a	chr13:110959544-110959554
9	CHD2	chr13:110959431-110959595	H1-hESC	embryonic stem cell:	n/a	chr13:110959544-110959554
10	CHD2	chr13:110959400-110959682	Hela-S3	cervix:	n/a	chr13:110959544-110959554
11	CTBP2	chr13:110958512-110960696	H1-hESC	embryonic stem cell:	n/a	n/a
12	CTCF	chr13:110958680-110958830	AoAF	blood vessel:	n/a	n/a
13	CTCF	chr13:110958720-110958870	SK-N-SH_RA	brain:	n/a	n/a
14	CTCF	chr13:110959260-110959410	WERI-Rb-1	eye:	n/a	n/a
15	CTCF	chr13:110956740-110956890	HMF	breast:	n/a	n/a
16	CTCF	chr13:110959349-110959426	Fibrobl	skin:	n/a	n/a
17	CTCF	chr13:110959300-110959450	HCFaa	heart:	n/a	n/a
18	CTCF	chr13:110958700-110958850	HCPEpiC	choroid plexus:	n/a	n/a
19	CTCF	chr13:110958700-110958850	HPAF	blood vessel:	n/a	n/a
20	CTCF	chr13:110958700-110958850	HPF	lung:	n/a	n/a
21	CTCF	chr13:110958760-110958910	AG04450	lung:	n/a	n/a
22	CTCF	chr13:110958720-110958870	AG04449	skin:	n/a	n/a
23	CTCF	chr13:110959640-110959790	HUVEC	blood vessel:	n/a	n/a
24	CTCF	chr13:110959340-110959490	SAEC	small airway:	n/a	n/a
25	CTCF	chr13:110958700-110958850	HUVEC	blood vessel:	n/a	n/a
26	CTCF	chr13:110958711-110958879	IMR90	lung:	n/a	n/a
27	CTCF	chr13:110958720-110958870	AG09319	gingival:	n/a	n/a
28	CTCF	chr13:110958720-110958870	HMF	breast:	n/a	n/a
29	CTCF	chr13:110958680-110958830	HRPEpiC	eye:	n/a	n/a
30	CTCF	chr13:110958820-110958970	HCM	heart:	n/a	n/a
31	CTCF	chr13:110959340-110959490	HCPEpiC	choroid plexus:	n/a	n/a
32	CTCF	chr13:110958720-110958870	HEEpiC	esophagus:	n/a	n/a
33	CTCF	chr13:110959358-110959384	NHEK	skin:	n/a	n/a
34	CTCF	chr13:110958840-110958990	BJ	skin:	n/a	n/a
35	CTCF	chr13:110958740-110958890	HCFaa	heart:	n/a	n/a
36	CTCF	chr13:110958800-110958950	AG09319	gingival:	n/a	n/a
37	CTCF	chr13:110959280-110959430	SK-N-SH_RA	brain:	n/a	n/a
38	CTCF	chr13:110959340-110959490	AG04449	skin:	n/a	n/a
39	CTCF	chr13:110958680-110958830	HBMEC	blood vessel:	n/a	n/a
40	CTCF	chr13:110958720-110958870	HPAF	blood vessel:	n/a	n/a
41	CTCF	chr13:110958720-110958870	NHDF-neo	bronchial:	n/a	n/a
42	CTCF	chr13:110959280-110959430	HUVEC	blood vessel:	n/a	n/a
43	CTCF	chr13:110958720-110958870	HVMF	connective:	n/a	n/a
44	CTCF	chr13:110958760-110958910	A549	lung:	n/a	n/a
45	CTCF	chr13:110958700-110958850	AoAF	blood vessel:	n/a	n/a
46	CTCF	chr13:110958640-110958790	HAc	cerebellar:	n/a	n/a
47	CTCF	chr13:110959340-110959490	HCM	heart:	n/a	n/a
48	CTCF	chr13:110958900-110959050	HRE	kidney:	n/a	n/a
49	CTCF	chr13:110958760-110958910	SK-N-SH_RA	brain:	n/a	n/a
50	CTCF	chr13:110958740-110958890	HEK293	kidney:	n/a	n/a

(count:794 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr13:110960177-110960227	GM19239	blood:	n/a
2	chr13:110960177-110960227	GM19239	blood:	n/a
3	chr13:110959428-110959478	NT2-D1	testis:	n/a
4	chr13:110959104-110959154	HRE	kidney:	n/a
5	chr13:110960198-110960248	Jurkat	blood:	n/a
6	chr13:110960186-110960236	NH-A	brain:	n/a
7	chr13:110960186-110960236	NHDF-neo	bronchial:	n/a
8	chr13:110956761-110956811	HRCEpiC	kidney:	n/a
9	chr13:110959104-110959154	PrEC	prostate:	n/a
10	chr13:110960177-110960227	HNPCEpiC	eye:	n/a
11	chr13:110958892-110958942	SK-N-MC	brain:	n/a
12	chr13:110956761-110956811	LNCaP	prostate:	n/a
13	chr13:110958977-110959027	PrEC	prostate:	n/a
14	chr13:110958977-110959027	HCPEpiC	choroid plexus:	n/a
15	chr13:110960198-110960248	AG04450	lung:	fetal
16	chr13:110959650-110959700	HUVEC	blood vessel:	n/a
17	chr13:110958418-110958468	HEK293	kidney:	embryo
18	chr13:110959356-110959406	HAEpiC	amniotic membrane:	n/a
19	chr13:110959428-110959478	SK-N-SH_RA	brain:	n/a
20	chr13:110959356-110959406	BE2_C	brain:	n/a
21	chr13:110959428-110959478	AG04449	skin:	fetal
22	chr13:110959647-110959697	RPTEC	kidney:	n/a
23	chr13:110960198-110960248	AoSMC	blood vessel:	n/a
24	chr13:110960186-110960236	HNPCEpiC	eye:	n/a
25	chr13:110960186-110960236	LNCaP	prostate:	n/a
26	chr13:110959650-110959700	HPAEpiC	pulmonary alveolar:	n/a
27	chr13:110960186-110960236	HepG2	liver:	n/a
28	chr13:110959428-110959478	ovcar-3	ovarian:	n/a
29	chr13:110960186-110960236	GM12891	blood:	n/a
30	chr13:110960177-110960227	RPTEC	kidney:	n/a
31	chr13:110959428-110959478	BE2_C	brain:	n/a
32	chr13:110958418-110958468	Jurkat	blood:	n/a
33	chr13:110959647-110959697	HCF	heart:	n/a
34	chr13:110958977-110959027	GM06990	blood:	n/a
35	chr13:110960177-110960227	ProgFib	skin:	n/a
36	chr13:110958977-110959027	HPAEpiC	pulmonary alveolar:	n/a
37	chr13:110959650-110959700	SAEC	small airway:	n/a
38	chr13:110959650-110959700	ovcar-3	ovarian:	n/a
39	chr13:110960186-110960236	SK-N-SH_RA	brain:	n/a
40	chr13:110959428-110959478	AoSMC	blood vessel:	n/a
41	chr13:110960186-110960236	RPTEC	kidney:	n/a
42	chr13:110959650-110959700	HEK293	kidney:	embryo
43	chr13:110959647-110959697	HEEpiC	esophagus:	n/a
44	chr13:110958418-110958468	A549	lung:	n/a
45	chr13:110959650-110959700	GM19239	blood:	n/a
46	chr13:110959647-110959697	A549	lung:	n/a
47	chr13:110959428-110959478	Hela-S3	cervix:	n/a
48	chr13:110958418-110958468	HRCEpiC	kidney:	n/a
49	chr13:110958418-110958468	HCPEpiC	choroid plexus:	n/a
50	chr13:110959356-110959406	K562	blood:	n/a

(count:3 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr13:110948351..110950288-chr13:110954842..110957509,2	K562	blood:
2	chr13:110955529..110957160-chr13:110983247..110985626,2	MCF-7	breast:
3	chr13:110951727..110953711-chr13:110957949..110960529,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-CARKD-3	chr13:110959614-110959875	NONHSAT035142
2	lnc-CARKD-3	chr13:110960207-110960294	NONHSAT035142

No data

Variant related genes	Relation type
COL4A1	TF binding region
COL4A2	TF binding region
COL4A1	CpG island
COL4A2	CpG island
ENSG00000187498	chromatin interactions
ENSG00000134871	chromatin interactions

Extended variants
information (count: 348 )
Associated
traits (count: 93 )

Variant overlapped rSNPs/rCNVs (count:348 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9301445	chr13:110951487-110951488	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
2	rs2029767	chr13:110951529-110951530	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs181895202	chr13:110951557-110951558	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs2029766	chr13:110951562-110951563	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs578236403	chr13:110951574-110951575	Flanking Active TSS Enhancers Genic enhancers Weak transcription Strong transcription Bivalent Enhancer Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs139983681	chr13:110951608-110951609	Enhancers Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs556045483	chr13:110951629-110951630	Enhancers Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs186087025	chr13:110951636-110951637	Enhancers Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs529422307	chr13:110951641-110951642	Enhancers Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs145448008	chr13:110951673-110951674	Enhancers Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs114253640	chr13:110951696-110951697	Enhancers Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs367599421	chr13:110951718-110951719	Enhancers Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs2029765	chr13:110951719-110951720	Enhancers Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs188988142	chr13:110951786-110951787	Enhancers Weak transcription Strong transcription Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs377590968	chr13:110951827-110951828	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs571212864	chr13:110951849-110951850	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs533797330	chr13:110951915-110951916	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs369192447	chr13:110951917-110951918	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs374257542	chr13:110951964-110951965	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs547208250	chr13:110951968-110951969	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs567097573	chr13:110952021-110952022	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs566687576	chr13:110952023-110952024	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs903355	chr13:110952028-110952029	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs555967746	chr13:110952061-110952062	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs369807990	chr13:110952119-110952120	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs73619244	chr13:110952150-110952151	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs376722370	chr13:110952178-110952179	Enhancers Weak transcription Strong transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs538251723	chr13:110952304-110952305	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs1928451	chr13:110952326-110952327	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs3908617	chr13:110952335-110952336	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs540894040	chr13:110952374-110952375	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs538827400	chr13:110952411-110952412	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs554436275	chr13:110952442-110952443	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs181435763	chr13:110952451-110952452	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs543149124	chr13:110952468-110952469	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs186473090	chr13:110952469-110952470	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs531786087	chr13:110952470-110952471	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs545084996	chr13:110952485-110952486	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs191356734	chr13:110952493-110952494	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs182728258	chr13:110952522-110952523	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs1888006	chr13:110952525-110952526	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs567154902	chr13:110952580-110952581	Weak transcription Strong transcription Genic enhancers Enhancers Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs3884492	chr13:110952609-110952610	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs529838084	chr13:110952659-110952660	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs376948652	chr13:110952684-110952685	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs549893503	chr13:110952693-110952694	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs569653127	chr13:110952722-110952723	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs538685789	chr13:110952729-110952730	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs369115670	chr13:110952737-110952738	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs552260790	chr13:110952752-110952753	Weak transcription Strong transcription Genic enhancers Enhancers Active TSS Bivalent Enhancer	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:93)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
HIV/AIDS	22032296	CNVD
Prostate cancer	16705090	CNVD
High-proliferative meningiomas	17937814	CNVD
Cancer	20164919	CNVD
Chordoma	21602918	CNVD
Bladder cancer	21949216	CNVD
Acute myeloid leukemia	16864856	CNVD
Burkitt''s lymphoma	18698080	CNVD
Cancer	21637783	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	21518781	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Ovarian cancer	20844748	CNVD
Colorectal cancer	19359472	CNVD
Intracranial aneurysm	19064780	CNVD
Breast cancer	19287154	CNVD
Acute myeloid leukemia	18379011	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Multiple myeloma	17077331	CNVD
Ependymoma	16718352	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Colorectal cancer	16272173	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Ovarian cancer	22174824	CNVD
Myoepithelioma	18604193	CNVD
Breast cancer	17133270	CNVD
Prostate cancer	18632612	CNVD
Melanoma	18172304	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	17053054	CNVD
Gastric cancer	17908304	CNVD
Liposarcoma	21253554	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Esophageal cancer	21851588	CNVD
Breast cancer	22032731	CNVD
Wilms tumour	21544195	CNVD
Thyroid cancer	19087340	CNVD
abortions and stillbirths	19751515	CNVD
Acute myeloid leukemia	21251322	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Burkitt''s lymphoma	20823134	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Burkitt''s lymphoma	19759907	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Medulloblastoma	19270706	CNVD
Mental retardation	17124404	CNVD
Leukemia	18688285	CNVD
Breast cancer	21785460	CNVD
Breast cancer	21858162	CNVD
Melanoma	17363583	CNVD
Developmental delay	21147756	CNVD
Breast cancer	21364760	CNVD
Colorectal cancer	21645411	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Breast cancer	16608533	CNVD
Glioblastoma multiforme	22286061	CNVD
Follicular lymphoma	20505157	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
abnormal development	18461090	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Malignant glioma	17146433	CNVD
Congenital anomalies of the kidney and urinary tract	20467480	CNVD
Glioma	17123091	CNVD
Sudden cardiac death	19188705	CNVD
Breast cancer	20409316	CNVD
Central neurocytomas	17123091	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Neurocytoma	17123091	CNVD
Mantle cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:641 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr13:110936200-110958800	Weak transcription	Gastric	stomach
2	chr13:110937000-110955400	Weak transcription	A549	lung
3	chr13:110937400-110952000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
4	chr13:110940400-110953600	Weak transcription	NHEK	skin
5	chr13:110945600-110955600	Weak transcription	Pancreas	Pancrea
6	chr13:110947400-110952600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
7	chr13:110948200-110951600	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr13:110948200-110952600	Strong transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
9	chr13:110948200-110954200	Genic enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
10	chr13:110948600-110954200	Genic enhancers	NH-A	brain
11	chr13:110949000-110952800	Strong transcription	Osteobl	bone
12	chr13:110949400-110954600	Enhancers	Fetal Heart	heart
13	chr13:110949400-110956800	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
14	chr13:110949600-110951800	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
15	chr13:110950000-110951800	Enhancers	HUES64 Cell Line	embryonic stem cell
16	chr13:110950600-110951600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
17	chr13:110950600-110951600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
18	chr13:110950600-110951800	Enhancers	iPS-18 Cell Line	embryonic stem cell
19	chr13:110950600-110952000	Enhancers	HUES48 Cell Line	embryonic stem cell
20	chr13:110950600-110952000	Enhancers	iPS-15b Cell Line	embryonic stem cell
21	chr13:110950600-110953600	Strong transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
22	chr13:110950600-110956600	Enhancers	NHDF-Ad	bronchial
23	chr13:110950800-110951800	Enhancers	H1 Cell Line	embryonic stem cell
24	chr13:110950800-110951800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
25	chr13:110950800-110951800	Strong transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
26	chr13:110950800-110952000	Enhancers	iPS-20b Cell Line	embryonic stem cell
27	chr13:110950800-110952000	Flanking Active TSS	Rectal Smooth Muscle	rectum
28	chr13:110950800-110952200	Strong transcription	Breast Myoepithelial Primary Cells	Breast
29	chr13:110950800-110956200	Genic enhancers	Fetal Muscle Leg	muscle
30	chr13:110951000-110951600	Genic enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
31	chr13:110951000-110951600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
32	chr13:110951000-110951600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
33	chr13:110951000-110951600	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr13:110951000-110951600	Flanking Active TSS	NHLF	lung
35	chr13:110951000-110951800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
36	chr13:110951000-110951800	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
37	chr13:110951000-110951800	Strong transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
38	chr13:110951000-110951800	Enhancers	Colonic Mucosa	Colon
39	chr13:110951000-110951800	Enhancers	Right Ventricle	heart
40	chr13:110951000-110951800	Enhancers	Spleen	Spleen
41	chr13:110951000-110952000	Genic enhancers	Fetal Muscle Trunk	muscle
42	chr13:110951000-110952200	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
43	chr13:110951000-110952200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
44	chr13:110951000-110952200	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
45	chr13:110951000-110952200	Enhancers	Esophagus	oesophagus
46	chr13:110951000-110952200	Genic enhancers	Lung	lung
47	chr13:110951000-110954200	Genic enhancers	Fetal Stomach	stomach
48	chr13:110951000-110956200	Genic enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
49	chr13:110951200-110951600	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
50	chr13:110951200-110951600	Strong transcription	Cortex derived primary cultured neurospheres	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links